» Articles » PMID: 30543583

Detection and Analysis of the Hedgehog Signaling Pathway-Related Long Non-Coding RNA (lncRNA) Expression Profiles in Keloid

Overview
Journal Med Sci Monit
Date 2018 Dec 14
PMID 30543583
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

BACKGROUND Hedgehog (Hh) signaling pathway-related genes have important roles in several physiological and disease processes that involve cell proliferation. Long non-coding region RNAs (lncRNAs) have a regulatory role on gene expression. Keloid is characterized by excessive proliferation of scar tissue following trauma. The aims of this study were to evaluate the Hh signaling pathway in keloid skin tissues and its downstream gene expression and lncRNAs, compared with normal skin. MATERIAL AND METHODS Four pairs of keloids and adjacent normal skin epidermis underwent total RNA extraction. Gene chip high-throughput real-time quantitative polymerase chain reaction (qPCR) was used to examine the differential expression profiles of the Hh signaling pathway-related lncRNAs and mRNAs in the human keloid and normal skin. The differentially expressed mRNAs were analyzed by Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) to identify their biological roles. RESULTS In keloid tissue, differential expression of 33 mRNAs and 30 lncRNAs relating to the Hh pathway, were verified by gene chip qPCR. The results of GO and KEGG analysis showed that the upregulated mRNAs were involved in cell proliferation, cell growth, and tissue repair, and down-regulated mRNAs were involved in apoptosis. The lncRNA, AC073257.2, affected cell keloid growth and proliferation by its upstream target the GLI2 gene at the transcriptional level. The lncRNA, HNF1A-AS1, affected cell keloid growth and proliferation by its neighboring target gene, HNF1A. CONCLUSIONS Differential expression occurred in Hh signaling pathway-related lncRNAs and mRNAs, which may provide further insight into the development of keloid.

Citing Articles

The HEDGEHOG-GLI1 pathway is important for fibroproliferative properties in keloids and as a candidate therapeutic target.

Tosa M, Abe Y, Egawa S, Hatakeyama T, Iwaguro C, Mitsugi R Commun Biol. 2023; 6(1):1235.

PMID: 38062202 PMC: 10703807. DOI: 10.1038/s42003-023-05561-z.


Progress in the clinical treatment of keloids.

Qi W, Xiao X, Tong J, Guo N Front Med (Lausanne). 2023; 10:1284109.

PMID: 38046417 PMC: 10690427. DOI: 10.3389/fmed.2023.1284109.


Congress Report on the Second World Congress of Global Scar Society with Scar Academy and Japan Scar Workshop.

Abdelhakim M, Dohi T, Ogawa R Plast Reconstr Surg Glob Open. 2023; 11(4):e4921.

PMID: 37073255 PMC: 10106224. DOI: 10.1097/GOX.0000000000004921.


An updated review of the immunological mechanisms of keloid scars.

Lee C, Tsai C, Chen C, Yeh Y, Chung W, Chen C Front Immunol. 2023; 14:1117630.

PMID: 37033989 PMC: 10075205. DOI: 10.3389/fimmu.2023.1117630.


Emerging role of non-coding RNAs in the regulation of Sonic Hedgehog signaling pathway.

Ghafouri-Fard S, Khoshbakht T, Hussen B, Taheri M, Samsami M Cancer Cell Int. 2022; 22(1):282.

PMID: 36100906 PMC: 9469619. DOI: 10.1186/s12935-022-02702-y.


References
1.
Shih D, Bussen M, Sehayek E, Ananthanarayanan M, Shneider B, Suchy F . Hepatocyte nuclear factor-1alpha is an essential regulator of bile acid and plasma cholesterol metabolism. Nat Genet. 2001; 27(4):375-82. DOI: 10.1038/86871. View

2.
Butler P, Longaker M, Yang G . Current progress in keloid research and treatment. J Am Coll Surg. 2008; 206(4):731-41. DOI: 10.1016/j.jamcollsurg.2007.12.001. View

3.
Gupta R, Shah N, Wang K, Kim J, Horlings H, Wong D . Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010; 464(7291):1071-6. PMC: 3049919. DOI: 10.1038/nature08975. View

4.
Javelaud D, Alexaki V, Dennler S, Mohammad K, Guise T, Mauviel A . TGF-β/SMAD/GLI2 signaling axis in cancer progression and metastasis. Cancer Res. 2011; 71(17):5606-10. PMC: 3165102. DOI: 10.1158/0008-5472.CAN-11-1194. View

5.
Profyris C, Tziotzios C, Do Vale I . Cutaneous scarring: Pathophysiology, molecular mechanisms, and scar reduction therapeutics Part I. The molecular basis of scar formation. J Am Acad Dermatol. 2011; 66(1):1-10. DOI: 10.1016/j.jaad.2011.05.055. View